Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: A 2-year randomized, double-blind, controlled study

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 1123-1129

  Atteritano, M ^a   Mazzaferro, S ^a   Bitto, A ^a   Cannata, M L ^b   D'Anna, R ^b   Squadrito, F ^a   Macri I ^a   Frisina, A ^a   Frisina, N ^a   Bagnato, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Genistein; Osteopenia; Postmenopausal; Quality of life

Indexed keywords

GENISTEIN; PHYTOESTROGEN;

AGED; BLOOD; BONE DENSITY; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE; FEMUR NECK; HUMAN; LUMBAR VERTEBRA; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; BONE DENSITY; BONE DISEASES, METABOLIC; DEPRESSION; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR NECK; GENISTEIN; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; PHYTOESTROGENS; POSTMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84894564921     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2512-5     Document Type: Article

References (35)

1. Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63
2. Hedlund LR, Gallagher JC (1989) The effect of age and menopause on bone mineral density of the proximal femur. J Bone Miner Res 44:639-642
3. Wark JD (1996) Osteoporotic fractures: background and prevention strategies. Maturitas 232:193-207
4. Blumel JE, Castelo-Branco C, Binfa L et al (2000) Quality of life after the menopause: a population study. Maturitas 341:17-23
5. Ravnikar VA (1992) Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Women Health Iss 22:75-80
6. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3):321-333
7. Collaborative group on Hormonal Factors in Breast Cancer Breast Cancer and hormone replacement therapy (1997) Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350:1047-1059
8. Beral V (2003) Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419-427
9. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2883:321-333
10. Atteritano M, Marini H, Polito F et al (2007) Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study. J Clin Endocr Metab 92(8):3068-3075
11. D'Anna R, Cannata ML, Atteritano M et al (2007) Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 14(4):648-655
12. Marini H, Bitto A, Altavilla D et al (2010) Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutr Metab Cardiovasc Dis 20(5):332-40
13. Marini H, Bitto A, Altavilla D et al (2008) Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 93(12):4787-96
14. Trifiletti A, Gaudio A, Lasco A, Atteritano M, Scamardi R, Pizzoleo MA, Morabito N, Frisina N (2008) Haemostatic effects of phytoestrogen genistein in postmenopausal women. Thromb Res 123(2):231-235
15. Atteritano M, Pernice F, Mazzaferro S et al (2008) Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. Eur J Pharmacol 589:22-26
16. Marini H, Minutoli L, Polito F et al (2007) Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study. Ann Intern Med 146(12):839-847
17. Atteritano M, Mazzaferro S, Frisina A et al (2009) Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporos Int 20(11):1947-1954
18. Testa MA, Nackley JF (1994) Methods for quality of life studies. Annu Rev Public Health 15:535-559
19. Cella DF (1995) Methods and problems in measuring quality of life. Support Care Cancer 3:11-22
20. Adlercreutz H, Wang GJ, Lapcik O et al (1998) Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265:208-215
21. Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025-1036
22. Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63-70
23. Chen Y, Lin SQ, Wei Y, Gao HL, Wang SH, Wu ZL (2008) Impact of menopause on quality of life in community-based women in China. Menopause 15:144-149
24. Chiu YW, Moore RW, Hsu CE, Huang CT, Liu HW, Chuang HY (2008) Factors influencing women's quality of life in the later half of life. Climacteric 11:201-211
25. Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV (2009) Menopause-specific questionnaire assessment in US population-based study showed negative impact on health-related quality of life. Maturitas 62:153-159
26. World Health Organization (1994) Quality of life assessment: international perspectives. Springer, Berlin
27. Golyan Tehrani SH, Mir Mohammad A, Mahmoudi M, Khaledian Z (2002) Study of quality of life and its patterns in different stages of menopause for women in Tehran. Hayat 8(3-4):33-41
28. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J (2005) Changes in women's attitude towards and use of hormone therapy after HERS and WHI. Maturitas 52:11-17
29. Genazzani AR, Schneider HPG, Panay N, Nijland EA (2006) The European menopause survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 22(7):369-375
30. Kok L, Kreijkamp-Kaspers S, Grobbee DE, Lampe JW, van der Schouw YT (2005) A randomized, placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause 12(1):56-62
31. Amato P, Young RL, Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Barnes S, Ellis KJ, Shypailo RJ, Fraley JK, Konzelmann KL, Fischer JG, Lasalle C, Smith EO, Wong WW (2013) Effect of soy isoflavone supplementation on menopausal quality of life. Menopause 20(4):443-447
32. Riesco E, Choquette S, Audet M, Tessier D, Dionne IJ (2011) Effect of exercise combined with phytoestrogens on quality of life in postmenopausal women. Climacteric 14(5):573-580
33. Rodríguez-Landa JF, Hernández-Figueroa JD, Hernández-Calderón Bdel C, Saavedra M (2009) Anxiolytic-like effect of phytoestrogen genistein in rats with long-term absence of ovarian hormones in the black and white model. Prog Neuropsychopharmacol Biol Psychiatry 33(2):367-72
34. Kageyama A, Sakakibara H, Zhou W, Yoshioka M, Ohsumi M, Shimoi K, Yokogoshi H (2010) Genistein regulated serotonergic activity in the hippocampus of ovariectomized rats under forced swimming stress. Biosci Biotechnol Biochem 74(10):2005-2010
35. Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J (2013) Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause 20:518-24